+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prognostic importance of human papillomavirus type 16 DNA in cervical cancer



Prognostic importance of human papillomavirus type 16 DNA in cervical cancer



Cancer 69(10): 2502-2504



Human papillomavirus (HPV) type 16 DNA is frequent in invasive cervical cancers. Among 43 patients with invasive cervical cancer, HPV-16-positive tumors spread to the parametrial and pelvic lymph nodes significantly more often than did HPV-16-negative tumors (P less than 0.05). Demonstration of HPV-16 DNA in invasive cervical cancers may be an additional prognostic factor for this disease.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041088465

Download citation: RISBibTeXText

PMID: 1314692

DOI: 10.1002/1097-0142(19920515)69:10<2502::aid-cncr2820691019>3.0.co;2-7


Related references

Possible prognostic significance of human papillomavirus type in cervical cancer. Gynecologic Oncology 29(3): 267-273, 1988

Prognostic significance of human papillomavirus type 16 and 18 in cervical cancer. Seoul Journal of Medicine 36(2): 53-60, 1995

Human papillomavirus type-distribution in cervical cancer in China: the importance of HPV 16 and 18. Cancer Causes and Control 20(9): 1705-1713, 2010

Human Papillomavirus Type-Distribution in Cervical Cancer in China: The Importance of Hpv 16 and 18. Cancer Causes & Control 20(9): 1705-1713, 2009

Prognostic significance of human papillomavirus (HPV) type and nuclear DNA content in invasive cervical cancer. International Journal of Gynecological Cancer 1(2): 59-67, 1991

Human papillomavirus L1 capsid protein and human papillomavirus type 16 as prognostic markers in cervical intraepithelial neoplasia 1. International Journal of Gynecological Cancer 20(2): 288-293, 2010

Human papillomavirus deoxyribonucleic acid as a prognostic indicator in early-stage cervical cancer: A possible role for type 18. American Journal of Obstetrics and Gynecology 173(5): 1461-1468, 1995

The prognostic role of serologic testing for antibody production against human papillomavirus type 16 E6 and E7 oncogenes in cervical cancer. Gynecologic Oncology 56(1): 138, 1995

Poster Prognostic Significance of Human Papillomavirus Dna Finding in Primary Cervical Cancer and Pelvic Lymph Nodes in Cervical Cancer Patients. European Journal of Cancer 47: S534-S535, 2011

Effects of human papillomavirus type-specific antisense oligonucleotides on cervical cancer cells containing papillomavirus type 16. Medical Oncology 11(3-4): 149-151, 1994

Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer. Journal of Virology 73(7): 5402-5410, 1999

The prevalence of human papillomavirus type 16 and 18 DNA in cervical cancer in different age groups: a study on the incidental cases of cervical cancer in Norway in 1983. Gynecologic Oncology 41(2): 141-148, 1991

Predictive testing of early cervical pre-cancer by detecting human papillomavirus E6/E7 mRNA in cervical cytologies up to high-grade squamous intraepithelial lesions: diagnostic and prognostic implications. Oncology Reports 19(2): 457-465, 2008

Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. Journal of Clinical Microbiology 44(5): 1755-1762, 2006

Independent prognostic role of human papillomavirus genotype in cervical cancer. Bmc Infectious Diseases 17(1): 391, 2017